A Randomized Triple-Blind Placebo-Controlled Study to Evaluate the Effects of a Supplement on Lower Urinary Tract Symptoms in Men.

Completed · Not applicable · Has a placebo group

Conditions studied: Lower Urinary Tract Symptoms, Benign Prostatic Hyperplasia, Erectile Dysfunction

In brief

This study aims to evaluate the effects of the ProstaThrive™ supplement on lower urinary tract symptoms (LUTS) in men. It is a 90-day virtual, randomized, placebo-controlled trial with 80 male participants aged 40 and above. The primary endpoint is the reduction in LUTS, while secondary endpoints include changes in sexual function and performance.

Key facts

Study ID

NCT06504472

Run by

Optimale

People needed

80

Starts

2024-02-07

Expected to finish

2024-06-24

Last updated by the study team

2024-07-16

Who can join

Age: 40 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Male participants aged 40+
• Experience symptoms such as frequent nighttime urination, incomplete bladder emptying, weak urinary stream, and frequent daytime urination
• Difficulty in getting or maintaining an erection
• Willing to avoid introducing any new products or medications targeting LUTS or erectile dysfunction during the study period

You may not qualify if…

• Recent surgeries or invasive treatments
• History of prostate or male reproductive cancers
• Urinary issues caused by neurological conditions
• Previous surgery on the genitals, prostate, bladder, or urethra
• Known allergies to product ingredients
• Diagnosed with chronic health conditions impacting study participation
• Current substance abuse
• Participation in other clinical trials
• Taking medications or supplements targeting LUTS or erectile dysfunction

Where it is running

• Citruslabs — Santa Monica, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.